BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16038732)

  • 1. 2-Methoxyestradiol at low dose induces differentiation of myeloma cells.
    Hou J; Xiong H; Gao W; Jiang H
    Leuk Res; 2005 Sep; 29(9):1059-67. PubMed ID: 16038732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular mechanism of myeloma cell line differentiation induced by 2-methoxyestradiol].
    Gao WR; Hou J; Xiong H
    Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):598-601. PubMed ID: 16532968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
    Jiang H; Gao W; Sze DM; Xiong H; Hou J
    Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordination of upregulated XBP-1 and downregulated c-myc during myeloma cell differentiation induced by 2-methoxyestradiol.
    Zhou X; Jiang H; Hou J
    Leuk Res; 2007 Sep; 31(9):1259-65. PubMed ID: 17257674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of 2-methoxyestradiol on cell differentiation of myeloma cell line CZ-1].
    Gao WR; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):197-9. PubMed ID: 15949258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary investigation of 2-methoxyestradiol inducing differentiation of myeloma cell line CZ-1.
    Hou J; Xiong H; Gao WR; Jiang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):65-9. PubMed ID: 16584594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of c-myc expression by Blimp-1 during the differentiation of myeloma cells].
    Zhou X; Zhou F; Jiang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):318-22. PubMed ID: 17877160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays.
    Chauhan D; Li G; Auclair D; Hideshima T; Richardson P; Podar K; Mitsiades N; Mitsiades C; Li C; Kim RS; Munshi N; Chen LB; Wong W; Anderson KC
    Blood; 2003 May; 101(9):3606-14. PubMed ID: 12480690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of different spliceosomes of overexpressed XBP-1 on differentiation of myeloma cells].
    Zou JF; Jiang H; Hou J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1181-5. PubMed ID: 21129257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of 2-methoxyestradiol on differentiation of primary myeloma cells].
    Gao WR; Hou J; Xiong H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):262-6. PubMed ID: 16638193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of low-dose 2-methoxyestradiol on the expressions of two isoforms of PRDM1 gene in myeloma].
    Jiang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):38-41. PubMed ID: 19563034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of the effect of 2-methoxyestradiol and arsenic trioxide on the apoptosis-associated gene expression profile of myeloma cells].
    Xiong H; Hou J; Gao WR; Chen QB
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):200-4. PubMed ID: 15949259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells.
    Chauhan D; Catley L; Hideshima T; Li G; Leblanc R; Gupta D; Sattler M; Richardson P; Schlossman RL; Podar K; Weller E; Munshi N; Anderson KC
    Blood; 2002 Sep; 100(6):2187-94. PubMed ID: 12200384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of 2-methoxyestradiol on proliferation and apoptosis of myeloma cell lines].
    Gao WR; Hou J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):293-7. PubMed ID: 15854295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.
    Wen XY; Stewart AK; Sooknanan RR; Henderson G; Hawley TS; Reimold AM; Glimcher LH; Baumann H; Malek LT; Hawley RG
    Int J Oncol; 1999 Jul; 15(1):173-8. PubMed ID: 10375612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism study on low dose tunicamycin inducing myeloma cells differentiation via unfolded protein response].
    Zou JF; Jiang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2010 Oct; 31(10):675-9. PubMed ID: 21223718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide and 2-methoxyestradiol reduce beta-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomib.
    Zhou L; Hou J; Fu W; Wang D; Yuan Z; Jiang H
    Leuk Res; 2008 Nov; 32(11):1674-83. PubMed ID: 18485479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.
    Carrasco DR; Sukhdeo K; Protopopova M; Sinha R; Enos M; Carrasco DE; Zheng M; Mani M; Henderson J; Pinkus GS; Munshi N; Horner J; Ivanova EV; Protopopov A; Anderson KC; Tonon G; DePinho RA
    Cancer Cell; 2007 Apr; 11(4):349-60. PubMed ID: 17418411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IPI-504, a novel and soluble HSP-90 inhibitor, blocks the unfolded protein response in multiple myeloma cells.
    Patterson J; Palombella VJ; Fritz C; Normant E
    Cancer Chemother Pharmacol; 2008 May; 61(6):923-32. PubMed ID: 17624530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma.
    Dingli D; Timm M; Russell SJ; Witzig TE; Rajkumar SV
    Clin Cancer Res; 2002 Dec; 8(12):3948-54. PubMed ID: 12473611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.